Vitamin E supplements in asthma: a parallel group randomised placebo controlled trial

Pearson, P. J. K.; Lewis, S. A.; Britton, J.; Fogarty, A.
August 2004
Thorax;Aug2004, Vol. 59 Issue 8, p652
Academic Journal
Background: Increased dietary vitamin E intake is associated with a reduced incidence of asthma, and combinations of antioxidant supplements including vitamin E are effective in reducing ozone induced bronchoconstriction. A study was undertaken to investigate the effect of supplementation with vitamin E for 6 weeks on bronchial hyperresponsiveness in atopic adults with asthma. Methods: 72 participants from a clinical trial register of adults with asthma were randomised to receive 500 mg natural vitamin E or matched placebo for 6 weeks in a placebo controlled, double blind parallel group clinical trial. Inclusion criteria included age 18-60 years, maintenance treatment of at least one dose of inhaled corticosteroid per day, a positive skin prick test to one of three common allergens, and bronchial hyperresponsiveness to methacholine (defined as a dose provoking a 20% fall in forced expiratory volume in I second (FEV1) (PD20) of 12.25 μmol). Secondary outcomes were FEV1, forced vital capacity, mean morning and evening peak How, symptom scores, bronchodilator use, and serum immunoglobulin E levels. Results: In the primary intention to treat analysis the change in PD20 was similar in the vitamin E and placebo groups with a mean difference of +0.25 doubling doses of methacholine (95% confidence interval -0.67 to +1.16 greater with vitamin E). There was no effect of vitamin E supplementation on any other measure of asthma control, either in the intention to treat or per protocol analysis. There was also no effect of vitamin E supplementation on serum immunoglobulin levels. Conclusion: Dietary supplementation with vitamin E adds no benefit to current standard treatment in adults with mild to moderate asthma.


Related Articles

  • Effects of thermally modified green tea catechins on the oxidative and hydrolytic stability of butter. Mika, Magdalena; Wikiera, Agnieszka; Żyla, Krzysztof // Health (1949-4998);Nov2009, Vol. 1 Issue 3, p192 

    Green tea catechins are classified as (-)-epiforms (2R, 3R) or (-)-forms (2S, 3R) with respect to stereoisomerism. The (-)-forms (2S, 3R) in catechin preparations obtained from green tea amounts to approximately 10% of total catechins, whereas the other 90% are (-)-epiforms (2R, 3R). High...

  • The Potential of PDE4 Inhibitors in Respiratory Disease. Spina, Domenico // Current Drug Targets - Inflammation & Allergy;Sep2004, Vol. 3 Issue 3, p231 

    Glucocorticosteroids remain the gold standard therapy for the prophylactic treatment of asthma. Concerns regarding its long-term use particularly in young children has provided an impetus for discovering novel anti-inflammatory molecules with high tolerability and clinical efficacy. Whilst for...

  • Review: allergen specific immunotherapies reduce symptoms, medication requirements, and bronchial hyper-reactivity in asthma. Abramson, M. J.; Puy, R. M.; Weiner, J. M. // Evidence Based Medicine;Jul/Aug2004, Vol. 9 Issue 4, p114 

    The article presents a study on allergen specific (AS) immunotherapy for asthma. 75 randomised controlled trials met the selection criteria. Patients who received AS immunotherapy had greater symptomatic improvement, had reduced asthma medication requirements, and were less likely to develop...

  • Dietary Antioxidants and Ozone-Induced Bronchial Hyperresponsiveness in Adults with Asthma. Trenga, Carol A.; Koenig, Jane Q.; Williams, Paul V. // Archives of Environmental Health;May/Jun2001, Vol. 56 Issue 3, p242 

    ABSTRACT. Ozone exposure aggravates asthma, as has been demonstrated in both controlled exposures and epidemiologic studies. In the current double-blind crossover study, the authors evaluated the effects of dietary antioxidants (i.e., 400 IU vitamin E/500 mg vitamin C) on ozone-induced bronchial...

  • Induction and Recovery Phases of Methacholine-induced Bronchoconstriction Using FEV1 According to the Degree of Bronchial Hyperresponsiveness. Mannino, F.; Sposato, B.; Ricci, A.; Grasso, D.; De Clementi, F.; Mariotta, S. // Lung;2001, Vol. 179 Issue 3, p137 

    Forty-eight patients suffering from intermittent bronchial asthma underwent methacholine challenge test. Response was stronger in 29 patients and less pronounced in 19. The two groups had the same characteristics except for the cumulative methacholine dose which was lower in severe...

  • Disposable diapers linked to asthma.  // Mothering;Jan/Feb2000, Issue 98, p35 

    Reports that a study published in the October 1999 issue of the `Archives of Environmental Health' found that laboratory mice exposed to various brands of disposable diapers suffered increased eye, nose and throat irritation, including bronchoconstriction similar to that of an asthma attack.

  • Comparison of 4 AM and 4 PM Bronchial Responsiveness to Hypertonic Saline in Asthma. Ferraz, Erica; Borges, Marcos C.; Terra-Filho, J.; Martinez, José A. B.; Vianna, Elcio O. // Lung;Nov/Dec2006, Vol. 184 Issue 6, p341 

    Bronchial responsiveness to methacholine or histamine increases at night and may contribute to the mechanisms of nocturnal asthma. Hypertonic saline (HS) is a more clinically relevant stimulus for the diagnosis and assessment of the severity of asthma, but the circadian variation in bronchial...

  • Chapter 15: Lessons learned from clinical trials of asthma. Sabin, Bradley R.; Avila, Pedro C.; Grammer, Leslie C.; Greenberger, Paul A. // Allergy & Asthma Proceedings;May/Jun2012 Supplement, Vol. 33, p51 

    The preponderance of clinical data suggest that inhaled corticosteroids (ICSs) are the preferred therapy for the long-term management of asthma, whereas oral or parental corticosteroids and short-acting beta2-adrenergic agonists remain the mainstay treatment of acute exacerbations. Allergen and...

  • Prescribing of β-adrenoceptor antagonists in asthma: an observational study. Morales, Daniel R.; Guthrie, Bruce; Lipworth, Brian J.; Donnan, Peter T.; Jackson, Cathy // Thorax;Jun2011, Vol. 66 Issue 6, p502 

    Background β-Antagonists have recently been proposed for the treatment of chronic asthma; however, concerns regarding risk of acute bronchoconstriction in clinical trials remain. Objective To determine the frequency of oral β-blocker prescribing in patients with asthma and associations...


Read the Article


Sign out of this library

Other Topics